Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds.
about
Discovery and development of Moxalactam (6059-S): the chemistry and biology of 1-oxacephemsPharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction.In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureusMoxalactam and cefazolin: comparative pharmacokinetics in normal subjects.In vitro studies of 1-oxacephalosporin (LY 127935), a new beta-lactam antibiotic.In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillinTentative interpretive standards for disk susceptibility tests with moxalactam (LY127935).Moxalactam pharmacokinetics in childrenA comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.Penetration and clearance of cefoperazone and moxalactam in pleural fluid.Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques.Moxalactam therapy for a wide spectrum of bacterial infections in adults.Comparative in vitro study in new cephalosporinsPharmacokinetics of moxalactam in patients with renal failure and during hemodialysisPenetration of ocular tissues and fluids by moxalactam in rabbits with staphylococcal endophthalmitis.Pharmacokinetics of ceftriaxone in humans.In vitro activity, efficacy, and pharmacology of moxalactam, a new beta-lactam antibioticMoxalactam penetration into cerebrospinal fluid in patients with bacterial meningitisComparative activities of 13 beta-lactam antibioticsCeftriaxone: in vitro studies and clinical evaluationComparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infectionRenal disposition of moxalactam in experimental animals as revealed by stop-flow analysis.Comparison of moxalactam and gentamicin in the treatment of complicated urinary tract infections.Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.Quality control of moxalactam susceptibility disks.In vitro activity and beta-lactamase stability of a new difluoro oxacephem, 6315-S.Activity of a new cephalosporin antibiotic, Ro 13-9904 against dense populations of selected enterobacteria.In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.Pharmacokinetics of moxalactam and cefazolin compared in normal volunteersComparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.Epimers of moxalactam: in vitro comparison of activity and stability.In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.Determination of moxalactam in human body fluids by liquid chromatographic and microbiological methods.
P2860
Q28263083-F820C6D2-A37C-44BE-B415-2F6D330AAD36Q30450692-9FAA1A78-AE35-4078-98DE-EAF8CAECBF91Q30451373-3585389D-E3A4-4454-9E71-94136270EBADQ30451388-3C844926-9F19-4C40-A01F-7589489A49F6Q33722704-53B923E7-6E20-4729-8CD0-08AAED7922DEQ33725629-39BE9E9C-9E16-48FD-B7A2-04B8684EEDBAQ33735948-A748BC32-101F-4C2E-9140-E721945C5443Q34250667-60198ADB-5E1B-416A-8030-2F571A6F3B33Q34707883-3A01AF0E-ED12-4326-9312-3CC167E9FF59Q34709946-304B93B0-D3AA-4F84-9154-12352D27B262Q35569002-AB01E8F0-B54A-4A27-A0FB-CCF512F8EECEQ35570935-324CA044-B94B-4B42-80B6-ECEAE4918374Q35669539-844E744E-6F18-4C36-86E4-B52DA08620B7Q35671193-A75520D3-3535-44EF-AF95-277220F49388Q35671542-9E88F4CC-B8E7-4E37-BFD2-A44B56DD37CBQ35671978-36E71C25-8E6D-49A1-A98D-2CC6C2760B09Q35672073-6A513B01-118D-403A-8128-9934BFA136D4Q35672113-612A8FF7-6B43-4170-802B-A68B77714864Q35674872-5A4FC91F-88C5-454F-9F51-07ED6E33862BQ35676188-462215E5-E320-427C-841B-3221DF1BDA78Q35712352-495390E5-6404-4032-9021-DAEDA6A8242EQ35715192-8D6A3C36-05D0-4AF4-85FE-7B0F94337782Q35739654-D5FF5A55-31AE-4A14-8A14-5B4212326702Q35754903-25D40F2D-8D8F-499B-A6BF-93EE795809A1Q35761938-A99179A7-8E00-4739-B5DB-754CF84C139AQ37291928-546C8C75-A4FA-4F5A-8E83-FC241BDB259EQ37308010-CE277031-F3A9-42A0-8264-266A26EF970CQ39834895-545E751D-7296-47B4-9580-0ADFB6CFB746Q39854371-46255C63-EA82-4542-8075-22942F5603E1Q39854523-6B292052-1FA7-415B-BED8-2A7AA6518985Q39854566-77EEDAD2-9549-4E9F-8AF8-3676D0DA51EEQ39854709-8E7E8482-5D9A-44EB-B258-82A046F825C4Q39854715-45BB7589-AA0D-4E9D-81FC-B4ECEB80BB31Q39854724-B7378F1E-44C7-4405-A587-9AEB9B8B2BA6Q39855029-56C8E5FD-8A26-4FFF-906E-5512632CFB46Q39855256-314EF9C2-7BB0-49C6-9529-1254AF345BF0Q39855402-BB829EB7-5CF6-4FB7-A0C1-F9AE93DF88DEQ39855525-BCB58A98-05CF-4343-89B5-7FBCD68D77ECQ39855592-8F63E85F-5333-409F-9852-BF1897856544Q39855613-B159C15F-724A-4702-96E8-230028B799A5
P2860
Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Antibacterial activity of a ne ...... f other beta-lactam compounds.
@en
type
label
Antibacterial activity of a ne ...... f other beta-lactam compounds.
@en
prefLabel
Antibacterial activity of a ne ...... f other beta-lactam compounds.
@en
P2093
P2860
P356
P1476
Antibacterial activity of a ne ...... f other beta-lactam compounds.
@en
P2093
P2860
P304
P356
10.1128/AAC.16.2.141
P407
P577
1979-08-01T00:00:00Z